U.S. Markets closed
  • S&P 500

    3,635.41
    +57.82 (+1.62%)
     
  • Dow 30

    30,046.24
    +454.97 (+1.54%)
     
  • Nasdaq

    12,036.79
    +156.15 (+1.31%)
     
  • Russell 2000

    1,853.53
    +35.23 (+1.94%)
     
  • Crude Oil

    44.83
    -0.08 (-0.18%)
     
  • Gold

    1,805.90
    +1.30 (+0.07%)
     
  • Silver

    23.27
    -0.03 (-0.13%)
     
  • EUR/USD

    1.1901
    +0.0004 (+0.0357%)
     
  • 10-Yr Bond

    0.8820
    +0.0250 (+2.92%)
     
  • Vix

    21.64
    -1.02 (-4.50%)
     
  • GBP/USD

    1.3361
    +0.0003 (+0.0214%)
     
  • USD/JPY

    104.4800
    0.0000 (0.0000%)
     
  • BTC-USD

    19,122.22
    +1.91 (+0.01%)
     
  • CMC Crypto 200

    380.29
    +10.54 (+2.85%)
     
  • FTSE 100

    6,432.17
    +98.33 (+1.55%)
     
  • Nikkei 225

    26,667.41
    +501.82 (+1.92%)
     

Rite Aid Surpasses 300 COVID-19 Testing Sites

·2 min read

Rite Aid (NYSE: RAD) continues to expand its no-charge COVID-19 testing service with 39 additional drive-through locations opening Friday, September 25, in California, Oregon, Michigan, Ohio, Pennsylvania, New Jersey, New York and Virginia, through its partnership with the U.S. Department of Health and Human Services (HHS).

Like Rite Aid’s existing drive-through testing sites, the new locations will utilize simple self-swab nasal tests overseen by Rite Aid pharmacists, and will operate Monday through Friday 10 a.m. - 8 p.m. and Saturday and Sunday 10 a.m. - 5 p.m.

Rite Aid’s COVID-19 nasal tests are available for all adults, regardless if they are experiencing virus symptoms, in accordance with the Centers for Disease Control and Prevention (CDC) guidance. At all testing locations, patients are required to provide government issued identification, be at least 18 years old and need to pre-register online at www.riteaid.com in order to schedule a time slot for testing.

Now operating 303 testing sites across 15 states, Rite Aid has adequate capacity to test symptomatic and asymptomatic individuals, 18 years and older, who want to be tested through online appointments. A complete list of Rite Aid's COVID-19 testing sites can be found at www.riteaid.com.

Rite Aid partners with Verily and its Baseline COVID-19 Testing Program to provide screening, scheduling and return of results to participants for Rite Aid testing sites.

BioReference Laboratories provides COVID-19 laboratory testing.

Clinical oversight for the COVID-19 testing program is provided by PWNHealth, a national clinician network that enables safe and easy access to diagnostic testing.

Rite Aid will continue to provide regular updates on the company's progress with COVID-19 testing.

About Rite Aid Corporation

Rite Aid Corporation is on the front lines of delivering healthcare services and retail products to more than 1.6 million Americans daily. Our pharmacists are uniquely positioned to engage with customers and improve their health outcomes. We provide an array of whole being health products and services for the entire family through over 2,400 retail pharmacy locations across 18 states. Through Elixir, we provide pharmacy benefits and services to approximately 4 million members nationwide. For more information, www.riteaid.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200924005037/en/

Contacts

MEDIA:
Chris Savarese
717-975-5718
christopher.savarese@riteaid.com